Dallah Healthcare Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Dallah Healthcare de 16% y 9.9% por año respectivamente. Se prevé que el BPA crezca en un 16.9% al año. Se espera que la rentabilidad financiera sea de 15.8% en 3 años.
Información clave
16.0%
Tasa de crecimiento de los beneficios
14.8%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 15.1% |
| Tasa de crecimiento de los ingresos | 9.6% |
| Rentabilidad financiera futura | 16.8% |
| Cobertura de analistas | Good |
| Última actualización | 06 Jun 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30
We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 3,824 | 602 | 502 | 730 | 7 |
| 12/31/2025 | 3,560 | 513 | 356 | 675 | 9 |
| 12/31/2024 | 3,305 | 436 | 290 | 578 | 6 |
| 3/31/2024 | 3,010 | 385 | 415 | 724 | N/A |
| 12/31/2023 | 2,943 | 360 | 329 | 626 | N/A |
| 9/30/2023 | 2,831 | 325 | 348 | 562 | N/A |
| 6/30/2023 | 2,682 | 270 | 369 | 549 | N/A |
| 3/31/2023 | 2,595 | 286 | 333 | 519 | N/A |
| 12/31/2022 | 2,488 | 274 | 267 | 442 | N/A |
| 9/30/2022 | 2,370 | 305 | 214 | 367 | N/A |
| 6/30/2022 | 2,313 | 311 | 122 | 260 | N/A |
| 3/31/2022 | 2,220 | 289 | 166 | 290 | N/A |
| 12/31/2021 | 2,105 | 259 | 246 | 362 | N/A |
| 9/30/2021 | 1,935 | 202 | 178 | 305 | N/A |
| 6/30/2021 | 1,742 | 206 | 240 | 363 | N/A |
| 3/31/2021 | 1,498 | 165 | 110 | 215 | N/A |
| 12/31/2020 | 1,318 | 132 | 54 | 183 | N/A |
| 9/30/2020 | 1,257 | 150 | 82 | 211 | N/A |
| 6/30/2020 | 1,207 | 123 | 35 | 198 | N/A |
| 3/31/2020 | 1,246 | 131 | 33 | 244 | N/A |
| 12/31/2019 | 1,252 | 147 | 106 | 307 | N/A |
| 9/30/2019 | 1,227 | 110 | 88 | 290 | N/A |
| 6/30/2019 | 1,206 | 115 | 43 | 264 | N/A |
| 3/31/2019 | 1,193 | 119 | 5 | 255 | N/A |
| 12/31/2018 | 1,181 | 142 | -51 | 204 | N/A |
| 9/30/2018 | 1,189 | 172 | -158 | 184 | N/A |
| 6/30/2018 | 1,203 | 217 | -131 | 253 | N/A |
| 3/31/2018 | 1,218 | 268 | -98 | 297 | N/A |
| 12/31/2017 | 1,212 | 295 | N/A | 353 | N/A |
| 9/30/2017 | 1,202 | 284 | N/A | 457 | N/A |
| 6/30/2017 | 1,180 | 268 | N/A | 387 | N/A |
| 3/31/2017 | 1,181 | 252 | N/A | 382 | N/A |
| 12/31/2016 | 1,163 | 225 | N/A | 343 | N/A |
| 9/30/2016 | 1,122 | 228 | N/A | 244 | N/A |
| 6/30/2016 | 1,073 | 194 | N/A | 261 | N/A |
| 3/31/2016 | 1,030 | 175 | N/A | 233 | N/A |
| 12/31/2015 | 985 | 165 | N/A | 214 | N/A |
| 9/30/2015 | 948 | 161 | N/A | 204 | N/A |
| 6/30/2015 | 917 | 156 | N/A | 168 | N/A |
| 3/31/2015 | 892 | 154 | N/A | 151 | N/A |
| 12/31/2014 | 859 | 147 | N/A | 149 | N/A |
| 9/30/2014 | 831 | 149 | N/A | 137 | N/A |
| 6/30/2014 | 805 | 149 | N/A | 138 | N/A |
| 3/31/2014 | 773 | 138 | N/A | 108 | N/A |
| 12/31/2013 | 750 | 137 | N/A | 102 | N/A |
| 9/30/2013 | 718 | 119 | N/A | 91 | N/A |
| 6/30/2013 | 693 | 121 | N/A | 107 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (16% al año) de 4004 es superior a la tasa de ahorro (14%).
Beneficios vs. Mercado: Se prevé que los beneficios (16% al año) de 4004 crezcan más rápidamente que el mercado SA (6.1% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de 4004 crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (9.9% al año) de 4004 crezcan más rápidamente que los del mercado SA (0.4% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 9.9% al año) de 4004 crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de 4004 sea baja dentro de 3 años (15.8%).